6681 Stock Overview

Develops medical-grade digital therapy (DTx) products for cognitive impairment. More details

6681 fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Rewards

Revenue grew by 142.7% over the past year

Risk Analysis

Has less than 1 year of cash runway

Shares are highly illiquid

Negative shareholders equity

My Notes

Capture your thoughts, links and company narrative

BrainAurora Medical Technology Limited Competitors

Yidu Tech

SEHK:2158

HK$4.6b

Medlive Technology

SEHK:2192

HK$6.5b

Sinohealth Holdings

SEHK:2361

HK$1.9b

Xunfei Healthcare Technology

SEHK:2506

HK$10.5b

Price History & Performance

Summary of share price highs, lows and changes for BrainAurora Medical Technology
Historical stock prices
Current Share Price	HK$4.40
52 Week High	HK$4.34
52 Week Low	HK$3.13
Beta	0
1 Month Change	n/a
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	32.13%

Recent updates

Shareholder Returns

	6681	HK Healthcare Services	HK Market
7D	n/a	-6.3%	-1.7%
1Y	n/a	-7.6%	16.5%

Return vs Industry: Insufficient data to determine how 6681 performed against the Hong Kong Healthcare Services industry.

Return vs Market: Insufficient data to determine how 6681 performed against the Hong Kong Market.

Price Volatility

Is 6681's price volatile compared to industry and market?
6681 volatility
6681 Average Weekly Movement	n/a
Healthcare Services Industry Average Movement	8.2%
Market Average Movement	6.8%
10% most volatile stocks in HK Market	14.5%
10% least volatile stocks in HK Market	3.2%

Stable Share Price: 6681's share price has been volatile over the past 3 months compared to the Hong Kong market.

Volatility Over Time: Insufficient data to determine 6681's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2012	157	Xiaoyi Wang	66nao.cn

BrainAurora Medical Technology Limited develops medical-grade digital therapy (DTx) products for cognitive impairment. The company offers the evaluation and intervention of cognitive impairments to treat vascular diseases, neurodegenerative diseases, psychological disorders, and child development deficiencies. It develops the Brain Function Information Management Platform software system, an evidence-based, medical-grade DTx product; Cognitive Ability Testing software; the Cognitive Ability Supplemental Screening and Assessment software; and the Dyslexia Supplemental Screening and Assessment software.

BrainAurora Medical Technology Limited Fundamentals Summary

How do BrainAurora Medical Technology's earnings and revenue compare to its market cap?
6681 fundamental statistics
Market cap	HK$5.50b
Earnings (TTM)	-HK$253.47m
Revenue (TTM)	HK$100.49m

55.4x

P/S Ratio

-22.0x

P/E Ratio

Is 6681 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6681 income statement (TTM)
Revenue	CN¥94.68m
Cost of Revenue	CN¥50.19m
Gross Profit	CN¥44.48m
Other Expenses	CN¥283.30m
Earnings	-CN¥238.81m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.19
Gross Margin	46.98%
Net Profit Margin	-252.25%
Debt/Equity Ratio	-162.8%

How did 6681 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/10 12:15
End of Day Share Price	2025/01/10 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

BrainAurora Medical Technology Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution

BrainAurora Medical Technology SEHK:6681 Stock Report